$MCOA is acquiring or JVing w/ companies across all sectors
Top 10 Most Recent News Articles
Finzly Welcomes Paul Finch to Drive BankOS Growth
Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...
Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday
A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...
Continue Reading
Wonder Create: Democratizing Restaurant Creation
Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...
Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks
Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...
Continue Reading
Legato Frames Put Tiny AI to a Real-World Hearing Test
A hearing aid that never enters the ear is a deceptively brutal product challenge. It has to hear speech through a mess of restaurant clatter, traffic, wind and ordinary human commotion; it has to run all day; and, crucially, it cannot look like a medical concession somebody reluctantly straps on. Legato Frames are aiming right at that knot, with femtoAI providing the...
Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close
One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...
Continue Reading
Midea's Cooling Systems Take Center Stage at DCW ME
AI Surge Demands Cooler Solutions Alright, who'd guess that data centers would feel the heat—literally—like a welder's furnace in Abu Dhabi? As AI demand burns hotter across the Middle East, data centers are sweating it out against 50°C-plus temperatures. We're talking about some serious pressure on traditional cooling methods that just can’t cut it anymore....
Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice
A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...
Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit
An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...
Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today
Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...
Continue ReadingTop 5 Most Recently Viewed Articles
Gold's Surge and Euro's Stagnation Amid Economic Shifts
Gold Gains Ground Amid Geopolitical Tensions Gold prices have recently shown an impressive rise, climbing 1.9% and breaking through the resistance level of $2,600. This rally followed a significant weekly decline in prices and reflects the market's reaction to ongoing geopolitical uncertainties. The surge in gold can be traced back to several influencing factors. One of...
Continue Reading
Teachable's Innovative Rebrand and Future Learning Vision
Teachable's Innovative Rebrand and Future Learning Vision Teachable, a leader in online education, proudly announces a new visual identity and a striking product vision that redefines the learning experience for everyone. As the platform continues to evolve, the changes reflect a deep commitment to meeting the needs of today’s learners and educators. A New Identity for...
Continue Reading
Functionize Elevates Software Testing with Advanced AI Solutions
Functionize Enhances Automation for Software Testing Automation Innovations Reshape Testing Using Natural Language Inputs to Create Reliable Tests and Streamline Complex Processes Across Enterprises Functionize, an innovative platform leveraging AI for software test case creation, has unveiled significant enhancements to its intelligent testing solutions. The recent...
Continue Reading
Anterix Inc. Delivers Strong Fiscal Performance This Quarter
Anterix Inc. Highlights Its Fiscal Progress Anterix Inc. (NASDAQ: ATEX), based in Woodlang Park, has recently revealed impressive results for its second quarter of fiscal 2026. The company has filed its Form 10-Q, reflecting the financial performance for the three and six months leading to september 30, 2025. During this quarter, Anterix provided an update on its...
Continue Reading
10X Genomics Futures Brighten with New Single Cell Products
10X Genomics Holds Steady with New Innovations 10X Genomics (NASDAQ: TXG) has received a reiterated Hold rating from TD Cowen, with a price target set at $20.00. This decision follows the company's announcement of plans to launch new Single Cell (SC) products during an industry event. The innovative products aim to provide cost-effective solutions focused on reducing...
Continue Reading